Matthias Barz is Professor of Biotherapeutic Delivery at the Division of BioTherapeutics at the Leiden Academic Center for Drug Research.
Matthias Barz studied chemistry at the Johannes Gutenberg-University Mainz (Germany) and Seoul National University (South Korea). After graduation in 2006 he received his PhD in polymer chemistry from the Johannes Gutenberg-University Mainz (Germany) working under the supervision of Prof. R. Zentel. Afterwards he worked in the laboratories of Dr. Maria J. Vicent at the CIPF (2010-2011) and Prof. T. Kirchhausen at Boston Children’s Hospital, Harvard Medical School (2011-2013) as a postdoctoral research fellow.
In 2013 he became independent junior research group leader and started his habilitation at the Institute of Organic Chemistry at the Johannes Gutenberg-University Mainz (Germany). After having received the venia legendi for organic chemistry in 2016 he joined the Leiden Academic Center for Drug Research (LACDR) as Full Professor for Biotherapeutic Delivery in 2020. His research focusses on the development of functional nanoparticles base on polypept(o)ides form diagnosis and therapy. Up to now, Matthias Barz has published more than 100 research papers, commentaries, reviews, book chapters and patents. For his independent research he received numerous awards, including the highly prestigious Chemiedozentenpreis (Young Faculty Award of the German Industry Fonds), the Young Faculty Scholarship of the Dr. Hermann-Schnell-Foundation, (German Chemical Society, Devision of Macromolecular Chemistry) and was named ACS PMSE Young Investigator in 2018.
No relevant ancillary activities